In summary, the results of our study suggest that TERT alterations occur frequently in adrenocortical carcinomas and not in adrenal adenomas, and that copy number gains/amplifications are much more frequent compared to “hotspot” promoter mutations. The gene discussed is TERT; the disease is adrenal cortex adenoma.